Journal Article

Addressing Opioid Dose Limits as a Route to Deterring Prescription Drug Abuse

March 25, 2019
  • Kimberly Lenz, PharmD, MBA, FAMCP Senior Pharmacy Director, MassHealth/Office of Clinical Affairs
  • Bonnie Greenwood, PharmD, BCPS Director, Clinical Programs, Clinical Pharmacy Services
  • Michael Angelini, MA, PharmD, BCPP
  • Karen Clements, ScD Senior Project Director, Research and Evaluation
  • Rose Mauro, MPH, CPh

A study by our pharmacy experts shows the positive impact of dose-limit policies implemented by a state Medicaid program. The team evaluated prior authorization policy-based opioid prescription limits implemented over a 15-year period and found that a sequential and progressive opioid dose reduction strategy was successful in decreasing the average daily opioid dose among Medicaid members in Massachusetts. It also showed a significant decrease in members receiving the highest doses. The results can be useful for policymakers and other Medicaid programs as they consider potential strategies to address the opioid epidemic.

https://www.jpain.org/article/S1526-5900(18)30439-5/fulltext